

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.11132348 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.10442764 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.10442764 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.06361161 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.06361161 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.75773973 |
| 7 | DNA deamination (GO:0045006) | 4.74829693 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.61669756 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.61471218 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.30498774 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.13522230 |
| 12 | negative T cell selection (GO:0043383) | 4.09441658 |
| 13 | negative thymic T cell selection (GO:0045060) | 3.96443666 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96069449 |
| 15 | detection of other organism (GO:0098543) | 3.92569222 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.85890141 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.85890141 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.85890141 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.85890141 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.85890141 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.85890141 |
| 22 | signal complex assembly (GO:0007172) | 3.79715792 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.67698817 |
| 24 | interferon-gamma production (GO:0032609) | 3.64462045 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 3.53075338 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.49525388 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.49428916 |
| 28 | response to peptidoglycan (GO:0032494) | 3.43192618 |
| 29 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.43051801 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.41928449 |
| 31 | response to interleukin-15 (GO:0070672) | 3.35234269 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34143677 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.32302331 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 3.30879580 |
| 35 | signal peptide processing (GO:0006465) | 3.30401888 |
| 36 | positive T cell selection (GO:0043368) | 3.28250598 |
| 37 | regulation of defense response to virus by virus (GO:0050690) | 3.27936418 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.25168642 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21869293 |
| 40 | thymic T cell selection (GO:0045061) | 3.21464778 |
| 41 | T cell selection (GO:0045058) | 3.18723165 |
| 42 | response to type I interferon (GO:0034340) | 3.13370032 |
| 43 | leukocyte aggregation (GO:0070486) | 3.12464352 |
| 44 | cellular response to type I interferon (GO:0071357) | 3.12087298 |
| 45 | type I interferon signaling pathway (GO:0060337) | 3.12087298 |
| 46 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.12080147 |
| 47 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.10404063 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08933666 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08366255 |
| 50 | positive regulation of granulocyte differentiation (GO:0030854) | 3.07280412 |
| 51 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.06955991 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.05626546 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.04964728 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00264740 |
| 55 | detection of external biotic stimulus (GO:0098581) | 2.96388727 |
| 56 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95699635 |
| 57 | endosome to melanosome transport (GO:0035646) | 2.94954213 |
| 58 | endosome to pigment granule transport (GO:0043485) | 2.94954213 |
| 59 | respiratory burst (GO:0045730) | 2.94776616 |
| 60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.94293567 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 2.94235033 |
| 62 | modulation by virus of host process (GO:0019054) | 2.93579038 |
| 63 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.90683409 |
| 64 | maturation of SSU-rRNA (GO:0030490) | 2.88560836 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.87850032 |
| 66 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.87314323 |
| 67 | pentose-phosphate shunt (GO:0006098) | 2.87179297 |
| 68 | rRNA modification (GO:0000154) | 2.87123246 |
| 69 | cellular response to interferon-beta (GO:0035458) | 2.85682885 |
| 70 | T cell receptor signaling pathway (GO:0050852) | 2.82972094 |
| 71 | regulation of response to interferon-gamma (GO:0060330) | 2.82090090 |
| 72 | T cell migration (GO:0072678) | 2.81424705 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81248885 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 2.78949197 |
| 75 | modulation by symbiont of host cellular process (GO:0044068) | 2.78609041 |
| 76 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.77748063 |
| 77 | negative regulation of innate immune response (GO:0045824) | 2.77454822 |
| 78 | rRNA methylation (GO:0031167) | 2.77220790 |
| 79 | Golgi transport vesicle coating (GO:0048200) | 2.74334420 |
| 80 | COPI coating of Golgi vesicle (GO:0048205) | 2.74334420 |
| 81 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.73350829 |
| 82 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.73350829 |
| 83 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.73296484 |
| 84 | negative regulation of phagocytosis (GO:0050765) | 2.72257395 |
| 85 | regulation of superoxide anion generation (GO:0032928) | 2.71835559 |
| 86 | sequestering of actin monomers (GO:0042989) | 2.71028012 |
| 87 | negative regulation of stress fiber assembly (GO:0051497) | 2.70326019 |
| 88 | response to interferon-beta (GO:0035456) | 2.70199657 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70021456 |
| 90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67654909 |
| 91 | response to host immune response (GO:0052572) | 2.67654909 |
| 92 | regulation of mast cell degranulation (GO:0043304) | 2.65706156 |
| 93 | tRNA methylation (GO:0030488) | 2.64434615 |
| 94 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.63943495 |
| 95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63915433 |
| 96 | neutrophil activation (GO:0042119) | 2.61536242 |
| 97 | T cell homeostasis (GO:0043029) | 2.61532039 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60119360 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.60064815 |
| 100 | granulocyte activation (GO:0036230) | 2.59564161 |
| 101 | response to host (GO:0075136) | 2.58477587 |
| 102 | response to host defenses (GO:0052200) | 2.58477587 |
| 103 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58477587 |
| 104 | immunoglobulin mediated immune response (GO:0016064) | 2.58291521 |
| 105 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57508899 |
| 106 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57026827 |
| 107 | mast cell activation (GO:0045576) | 2.56295501 |
| 108 | respiratory chain complex IV assembly (GO:0008535) | 2.55818040 |
| 109 | cellular response to interleukin-4 (GO:0071353) | 2.55799327 |
| 110 | pinocytosis (GO:0006907) | 2.55614787 |
| 111 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55377031 |
| 112 | detection of biotic stimulus (GO:0009595) | 2.54903808 |
| 113 | regulation of regulatory T cell differentiation (GO:0045589) | 2.54327700 |
| 114 | cotranslational protein targeting to membrane (GO:0006613) | 2.53707917 |
| 115 | viral transcription (GO:0019083) | 2.53422609 |
| 116 | NADH metabolic process (GO:0006734) | 2.52874319 |
| 117 | ribosomal small subunit biogenesis (GO:0042274) | 2.52102556 |
| 118 | response to muramyl dipeptide (GO:0032495) | 2.52048849 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.51917543 |
| 120 | detection of bacterium (GO:0016045) | 2.51613096 |
| 121 | metallo-sulfur cluster assembly (GO:0031163) | 2.51500076 |
| 122 | iron-sulfur cluster assembly (GO:0016226) | 2.51500076 |
| 123 | apoptotic process involved in morphogenesis (GO:0060561) | 2.50025693 |
| 124 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.49796054 |
| 125 | protein targeting to ER (GO:0045047) | 2.49645560 |
| 126 | cellular response to zinc ion (GO:0071294) | 2.48477784 |
| 127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47667616 |
| 128 | GDP-mannose metabolic process (GO:0019673) | 2.47612978 |
| 129 | regulation of T cell tolerance induction (GO:0002664) | 2.47055825 |
| 130 | proteasome assembly (GO:0043248) | 2.46387452 |
| 131 | regulation of necrotic cell death (GO:0010939) | 2.45782616 |
| 132 | negative regulation of T cell mediated immunity (GO:0002710) | 2.45686826 |
| 133 | megakaryocyte development (GO:0035855) | 2.45402842 |
| 134 | lymphocyte homeostasis (GO:0002260) | 2.44903343 |
| 135 | regulation of necroptotic process (GO:0060544) | 2.44676980 |
| 136 | germinal center formation (GO:0002467) | 2.44659679 |
| 137 | RNA methylation (GO:0001510) | 2.44218367 |
| 138 | termination of RNA polymerase III transcription (GO:0006386) | 2.43454161 |
| 139 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.43454161 |
| 140 | amino acid salvage (GO:0043102) | 2.43371083 |
| 141 | L-methionine salvage (GO:0071267) | 2.43371083 |
| 142 | L-methionine biosynthetic process (GO:0071265) | 2.43371083 |
| 143 | B cell mediated immunity (GO:0019724) | 2.42905478 |
| 144 | lymph node development (GO:0048535) | 2.42695957 |
| 145 | negative regulation of interleukin-12 production (GO:0032695) | 2.42486689 |
| 146 | protein localization to endoplasmic reticulum (GO:0070972) | 2.42412085 |
| 147 | mannose metabolic process (GO:0006013) | 2.42080127 |
| 148 | NADPH regeneration (GO:0006740) | 2.41558183 |
| 149 | protein localization to endosome (GO:0036010) | 2.41322113 |
| 150 | defense response to protozoan (GO:0042832) | 2.40314542 |
| 151 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.39636354 |
| 152 | mature B cell differentiation involved in immune response (GO:0002313) | 2.38696928 |
| 153 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.37406263 |
| 154 | leukocyte homeostasis (GO:0001776) | 2.37329572 |
| 155 | translational termination (GO:0006415) | 2.35982442 |
| 156 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.34492239 |
| 157 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.34246436 |
| 158 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.34117460 |
| 159 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.33574001 |
| 160 | platelet dense granule organization (GO:0060155) | 2.33371315 |
| 161 | regulation of histone H3-K27 methylation (GO:0061085) | 2.32786543 |
| 162 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.32230984 |
| 163 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.32230984 |
| 164 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.31603844 |
| 165 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.31481838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.50776691 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.31368262 |
| 3 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.91186744 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.90350397 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.78254073 |
| 6 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.76645594 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.72622243 |
| 8 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.70355955 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63047486 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51932369 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.51863760 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.50468778 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49324160 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.48476803 |
| 15 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.48426610 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40534015 |
| 17 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.36601882 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36110057 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33168742 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29935165 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.26395123 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.21376502 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21196756 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.20953166 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.20160640 |
| 26 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.19577247 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16311187 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11961881 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08493591 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.06929290 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.06357511 |
| 32 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.06288556 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.03049365 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00759746 |
| 35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98616691 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.98379810 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96350429 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96309101 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92774096 |
| 40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.90510071 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90151399 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89965384 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89095617 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87271932 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87003785 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86892497 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85406438 |
| 48 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.83147828 |
| 49 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82634490 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82227438 |
| 51 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.82068269 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78340116 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.76366479 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.76072723 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.72190135 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71282025 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.66142730 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65812691 |
| 59 | * MAF_26560356_Chip-Seq_TH1_Human | 1.65618122 |
| 60 | * MYB_26560356_Chip-Seq_TH1_Human | 1.65479718 |
| 61 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.65157323 |
| 62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64184471 |
| 63 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.62615285 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.60611303 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.59596539 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.58158155 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58101328 |
| 68 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57336333 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56796578 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55831767 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54643107 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52160104 |
| 73 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.52080891 |
| 74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51073316 |
| 75 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.51018212 |
| 76 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49562519 |
| 77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49193064 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.48844286 |
| 79 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48612434 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47927147 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46492838 |
| 82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46097377 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45583071 |
| 84 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44998602 |
| 85 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.43705060 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42955562 |
| 87 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.42643301 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42392441 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39823313 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39127024 |
| 91 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.35882361 |
| 92 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35372864 |
| 93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.34797143 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34152958 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34016732 |
| 96 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32979191 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32919177 |
| 98 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.31315232 |
| 99 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.30955723 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30751399 |
| 101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30059240 |
| 102 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28849072 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28247271 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26628628 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25178053 |
| 106 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24508339 |
| 107 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24125417 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23986552 |
| 109 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.23342612 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.22091649 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21660953 |
| 112 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21105884 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20178448 |
| 114 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19958961 |
| 115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19213300 |
| 116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18755445 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18335034 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17946281 |
| 119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17127359 |
| 120 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17005498 |
| 121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16849575 |
| 122 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16145132 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13409435 |
| 124 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12024141 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11743423 |
| 126 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11739498 |
| 127 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11482898 |
| 128 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11283645 |
| 129 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10762007 |
| 130 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10062831 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09826153 |
| 132 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08980359 |
| 133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08907878 |
| 134 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08321812 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08307305 |
| 136 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08163996 |
| 137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07944431 |
| 138 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.07876626 |
| 139 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06767614 |
| 140 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06703115 |
| 141 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05921389 |
| 142 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05807390 |
| 143 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05679965 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05584826 |
| 145 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05290379 |
| 146 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05257382 |
| 147 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04944145 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04522870 |
| 149 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.04192038 |
| 150 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04054527 |
| 151 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02085427 |
| 152 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99936801 |
| 153 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99843385 |
| 154 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98623337 |
| 155 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98159721 |
| 156 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97526384 |
| 157 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96578299 |
| 158 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95893290 |
| 159 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95471841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.95795484 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.93156428 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.63967527 |
| 4 | MP0003303_peritoneal_inflammation | 3.07959940 |
| 5 | MP0000685_abnormal_immune_system | 3.05203002 |
| 6 | MP0005451_abnormal_body_composition | 3.04742971 |
| 7 | MP0009785_altered_susceptibility_to | 2.64950434 |
| 8 | MP0001800_abnormal_humoral_immune | 2.63408814 |
| 9 | MP0001790_abnormal_immune_system | 2.43485674 |
| 10 | MP0005387_immune_system_phenotype | 2.43485674 |
| 11 | MP0002398_abnormal_bone_marrow | 2.40559169 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.35143549 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.33941174 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.33434674 |
| 15 | MP0001819_abnormal_immune_cell | 2.29390509 |
| 16 | MP0002723_abnormal_immune_serum | 2.28010803 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.21978662 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.21114947 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.13111001 |
| 20 | MP0005025_abnormal_response_to | 2.13000416 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.12356707 |
| 22 | MP0000716_abnormal_immune_system | 2.08405811 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.08141537 |
| 24 | MP0002132_abnormal_respiratory_system | 2.07923884 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.05450664 |
| 26 | MP0002722_abnormal_immune_system | 2.00651582 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.99824299 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.97192145 |
| 29 | MP0001873_stomach_inflammation | 1.95156446 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.89018477 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.84491333 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.83789185 |
| 33 | MP0002429_abnormal_blood_cell | 1.82760428 |
| 34 | MP0002405_respiratory_system_inflammati | 1.80144845 |
| 35 | MP0003724_increased_susceptibility_to | 1.79800842 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.75446265 |
| 37 | MP0009278_abnormal_bone_marrow | 1.74433483 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.73950313 |
| 39 | MP0002419_abnormal_innate_immunity | 1.71141334 |
| 40 | MP0001853_heart_inflammation | 1.69911745 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.69543419 |
| 42 | MP0003866_abnormal_defecation | 1.65459492 |
| 43 | MP0008058_abnormal_DNA_repair | 1.64678030 |
| 44 | MP0003436_decreased_susceptibility_to | 1.62985778 |
| 45 | MP0002006_tumorigenesis | 1.60347589 |
| 46 | MP0005310_abnormal_salivary_gland | 1.56319668 |
| 47 | MP0004147_increased_porphyrin_level | 1.55635561 |
| 48 | MP0004858_abnormal_nervous_system | 1.54440002 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.50892437 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.50592409 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.49969711 |
| 52 | MP0002796_impaired_skin_barrier | 1.49905662 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.47376684 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.47376684 |
| 55 | MP0004947_skin_inflammation | 1.46893409 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.44897360 |
| 57 | MP0001849_ear_inflammation | 1.41619842 |
| 58 | MP0003075_altered_response_to | 1.40207046 |
| 59 | MP0001764_abnormal_homeostasis | 1.36551331 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.35342665 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.34966639 |
| 62 | MP0003077_abnormal_cell_cycle | 1.33089679 |
| 63 | MP0006082_CNS_inflammation | 1.32436034 |
| 64 | MP0009840_abnormal_foam_cell | 1.29386000 |
| 65 | MP0008469_abnormal_protein_level | 1.29096663 |
| 66 | MP0004510_myositis | 1.28785739 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.27502741 |
| 68 | MP0002009_preneoplasia | 1.27180917 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.23801777 |
| 70 | MP0001851_eye_inflammation | 1.21662865 |
| 71 | MP0000490_abnormal_crypts_of | 1.21476740 |
| 72 | MP0003786_premature_aging | 1.19921310 |
| 73 | MP0001348_abnormal_lacrimal_gland | 1.17771809 |
| 74 | MP0010094_abnormal_chromosome_stability | 1.16712178 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.16039034 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.16014681 |
| 77 | MP0005365_abnormal_bile_salt | 1.15670172 |
| 78 | MP0003329_amyloid_beta_deposits | 1.14543427 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 1.12258892 |
| 80 | MP0005666_abnormal_adipose_tissue | 1.12046412 |
| 81 | MP0008057_abnormal_DNA_replication | 1.11987680 |
| 82 | MP0002095_abnormal_skin_pigmentation | 1.09606120 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 1.09570748 |
| 84 | MP0005166_decreased_susceptibility_to | 1.08183087 |
| 85 | MP0005501_abnormal_skin_physiology | 1.05963637 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.05114995 |
| 87 | MP0003172_abnormal_lysosome_physiology | 1.03332410 |
| 88 | MP0003186_abnormal_redox_activity | 1.02960803 |
| 89 | MP0004381_abnormal_hair_follicle | 1.01719913 |
| 90 | MP0002019_abnormal_tumor_incidence | 1.01458319 |
| 91 | MP0002998_abnormal_bone_remodeling | 1.00032825 |
| 92 | MP0003448_altered_tumor_morphology | 0.99660583 |
| 93 | MP0008260_abnormal_autophagy | 0.98311250 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 0.97469848 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 0.97315781 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.96475299 |
| 97 | MP0006292_abnormal_olfactory_placode | 0.95441967 |
| 98 | MP0008874_decreased_physiological_sensi | 0.93387475 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.91946438 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.88876721 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.88455818 |
| 102 | MP0000604_amyloidosis | 0.87617410 |
| 103 | MP0002933_joint_inflammation | 0.87174199 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.86808790 |
| 105 | MP0003828_pulmonary_edema | 0.86652901 |
| 106 | MP0003111_abnormal_nucleus_morphology | 0.86242883 |
| 107 | MP0000609_abnormal_liver_physiology | 0.86144183 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.86040105 |
| 109 | MP0000858_altered_metastatic_potential | 0.82470446 |
| 110 | MP0005083_abnormal_biliary_tract | 0.81720467 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.81441935 |
| 112 | MP0005409_darkened_coat_color | 0.81276222 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.81200040 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.80878183 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 0.78700188 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.77600196 |
| 117 | MP0006054_spinal_hemorrhage | 0.77484374 |
| 118 | MP0008004_abnormal_stomach_pH | 0.75932321 |
| 119 | MP0003806_abnormal_nucleotide_metabolis | 0.75881367 |
| 120 | MP0000313_abnormal_cell_death | 0.74808691 |
| 121 | MP0009931_abnormal_skin_appearance | 0.74519646 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.74186795 |
| 123 | MP0009697_abnormal_copulation | 0.73717383 |
| 124 | MP0003091_abnormal_cell_migration | 0.72280414 |
| 125 | MP0009763_increased_sensitivity_to | 0.72170813 |
| 126 | MP0008995_early_reproductive_senescence | 0.71803056 |
| 127 | MP0001666_abnormal_nutrient_absorption | 0.70746967 |
| 128 | MP0005390_skeleton_phenotype | 0.70717598 |
| 129 | MP0005330_cardiomyopathy | 0.70063239 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.68668875 |
| 131 | MP0000681_abnormal_thyroid_gland | 0.68323259 |
| 132 | MP0004233_abnormal_muscle_weight | 0.68218445 |
| 133 | MP0000343_altered_response_to | 0.68175251 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.67118688 |
| 135 | MP0002638_abnormal_pupillary_reflex | 0.66305929 |
| 136 | MP0008877_abnormal_DNA_methylation | 0.66242403 |
| 137 | MP0005621_abnormal_cell_physiology | 0.66121076 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66096567 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.63676142 |
| 140 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63372865 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.62717077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 4.28948100 |
| 2 | Abnormality of macrophages (HP:0004311) | 3.95893222 |
| 3 | Recurrent bronchitis (HP:0002837) | 3.87336992 |
| 4 | IgG deficiency (HP:0004315) | 3.72693219 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 3.71991077 |
| 6 | Chronic otitis media (HP:0000389) | 3.70760167 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.68191685 |
| 8 | T lymphocytopenia (HP:0005403) | 3.64239593 |
| 9 | Aplastic anemia (HP:0001915) | 3.43606772 |
| 10 | Abnormality of T cells (HP:0002843) | 3.40438625 |
| 11 | Agammaglobulinemia (HP:0004432) | 3.35821370 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.32578005 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29524450 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 3.27022382 |
| 15 | Myositis (HP:0100614) | 3.18416817 |
| 16 | Obstructive lung disease (HP:0006536) | 3.18131966 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18131966 |
| 18 | Recurrent viral infections (HP:0004429) | 3.14578630 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.11675726 |
| 20 | Thrombocytosis (HP:0001894) | 3.06694389 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.05260916 |
| 22 | Combined immunodeficiency (HP:0005387) | 3.03657505 |
| 23 | Hypoplasia of the thymus (HP:0000778) | 2.96709660 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.95277417 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91298150 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91298150 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 2.91054146 |
| 28 | Abnormality of B cell number (HP:0010975) | 2.85959991 |
| 29 | B lymphocytopenia (HP:0010976) | 2.85959991 |
| 30 | Purpura (HP:0000979) | 2.85201064 |
| 31 | Lymphopenia (HP:0001888) | 2.82335924 |
| 32 | Increased IgM level (HP:0003496) | 2.78983285 |
| 33 | Bronchitis (HP:0012387) | 2.78008215 |
| 34 | Cellulitis (HP:0100658) | 2.77093622 |
| 35 | Nasal polyposis (HP:0100582) | 2.76924960 |
| 36 | Recurrent sinusitis (HP:0011108) | 2.75933497 |
| 37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.75803847 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.74765951 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.72419769 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.71201499 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.70710116 |
| 42 | Chronic diarrhea (HP:0002028) | 2.67037833 |
| 43 | Urticaria (HP:0001025) | 2.66639989 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.65955646 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.62759632 |
| 46 | Thyroiditis (HP:0100646) | 2.62684454 |
| 47 | Pustule (HP:0200039) | 2.60104534 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.57805923 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.53592406 |
| 50 | Granulocytopenia (HP:0001913) | 2.52367737 |
| 51 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.48570831 |
| 52 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.48570831 |
| 53 | Abnormal protein glycosylation (HP:0012346) | 2.48570831 |
| 54 | Abnormal glycosylation (HP:0012345) | 2.48570831 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.46471738 |
| 56 | Ragged-red muscle fibers (HP:0003200) | 2.45894090 |
| 57 | Meningitis (HP:0001287) | 2.44146784 |
| 58 | Abnormal number of erythroid precursors (HP:0012131) | 2.44009246 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.43499152 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.38168185 |
| 61 | 3-Methylglutaconic aciduria (HP:0003535) | 2.36876792 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.36418148 |
| 63 | Stomatitis (HP:0010280) | 2.35902562 |
| 64 | Reticulocytopenia (HP:0001896) | 2.35833396 |
| 65 | Eosinophilia (HP:0001880) | 2.34612363 |
| 66 | Gingivitis (HP:0000230) | 2.33014577 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.32197880 |
| 68 | Recurrent skin infections (HP:0001581) | 2.30950862 |
| 69 | Myopathic facies (HP:0002058) | 2.29780182 |
| 70 | Lymphoma (HP:0002665) | 2.28882152 |
| 71 | Chest pain (HP:0100749) | 2.26274772 |
| 72 | 11 pairs of ribs (HP:0000878) | 2.25205984 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.25040168 |
| 74 | Slow saccadic eye movements (HP:0000514) | 2.24753084 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.22936510 |
| 76 | Cholecystitis (HP:0001082) | 2.22936510 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.22235962 |
| 78 | Increased serum ferritin (HP:0003281) | 2.21580987 |
| 79 | Petechiae (HP:0000967) | 2.21368930 |
| 80 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20971791 |
| 81 | Dry hair (HP:0011359) | 2.20143395 |
| 82 | Hepatic necrosis (HP:0002605) | 2.19921985 |
| 83 | Neutropenia (HP:0001875) | 2.19324800 |
| 84 | Polygenic inheritance (HP:0010982) | 2.19322661 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.19209719 |
| 86 | Pancytopenia (HP:0001876) | 2.18350963 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.18331845 |
| 88 | Colitis (HP:0002583) | 2.16010917 |
| 89 | Hypoproteinemia (HP:0003075) | 2.15182174 |
| 90 | Gastrointestinal stroma tumor (HP:0100723) | 2.14408742 |
| 91 | Gastrointestinal inflammation (HP:0004386) | 2.11974834 |
| 92 | Encephalitis (HP:0002383) | 2.11922143 |
| 93 | Loss of speech (HP:0002371) | 2.11682483 |
| 94 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.11488571 |
| 95 | Hypertensive crisis (HP:0100735) | 2.10814088 |
| 96 | Joint swelling (HP:0001386) | 2.09870799 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.09529585 |
| 98 | Abnormality of the fingertips (HP:0001211) | 2.07762139 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 2.07459108 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.05760536 |
| 101 | Inflammation of the large intestine (HP:0002037) | 2.04737837 |
| 102 | Retrobulbar optic neuritis (HP:0100654) | 2.04495783 |
| 103 | Optic neuritis (HP:0100653) | 2.04495783 |
| 104 | Hepatocellular necrosis (HP:0001404) | 2.03158601 |
| 105 | IgA deficiency (HP:0002720) | 2.03089406 |
| 106 | Gastrointestinal dysmotility (HP:0002579) | 2.03014443 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 2.02896938 |
| 108 | Acute hepatic failure (HP:0006554) | 2.02654366 |
| 109 | Microvesicular hepatic steatosis (HP:0001414) | 2.01455244 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00552693 |
| 111 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99067384 |
| 112 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99067384 |
| 113 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99067384 |
| 114 | Hypochromic anemia (HP:0001931) | 1.99035187 |
| 115 | Amaurosis fugax (HP:0100576) | 1.99021083 |
| 116 | Exercise-induced myalgia (HP:0003738) | 1.98378790 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.98328039 |
| 118 | Renal cortical cysts (HP:0000803) | 1.97926653 |
| 119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.97208217 |
| 120 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.96734681 |
| 121 | Increased IgE level (HP:0003212) | 1.96669470 |
| 122 | Gingival bleeding (HP:0000225) | 1.95340049 |
| 123 | Spontaneous hematomas (HP:0007420) | 1.95132195 |
| 124 | Epistaxis (HP:0000421) | 1.94901459 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 1.94116384 |
| 126 | Hypercortisolism (HP:0001578) | 1.92726561 |
| 127 | Orchitis (HP:0100796) | 1.92641017 |
| 128 | Growth hormone excess (HP:0000845) | 1.92335699 |
| 129 | Skin rash (HP:0000988) | 1.91334394 |
| 130 | Leukocytosis (HP:0001974) | 1.91081479 |
| 131 | Hypertriglyceridemia (HP:0002155) | 1.91032820 |
| 132 | Increased connective tissue (HP:0009025) | 1.90722620 |
| 133 | Chronic sinusitis (HP:0011109) | 1.90498174 |
| 134 | Abnormality of the anterior horn cell (HP:0006802) | 1.90136120 |
| 135 | Degeneration of anterior horn cells (HP:0002398) | 1.90136120 |
| 136 | Birth length less than 3rd percentile (HP:0003561) | 1.89887630 |
| 137 | Poikiloderma (HP:0001029) | 1.89764780 |
| 138 | Vasculitis (HP:0002633) | 1.87830616 |
| 139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87778524 |
| 140 | Skin ulcer (HP:0200042) | 1.87683421 |
| 141 | Cheilitis (HP:0100825) | 1.85409282 |
| 142 | Neuronal loss in central nervous system (HP:0002529) | 1.83763768 |
| 143 | Arterial thrombosis (HP:0004420) | 1.82348855 |
| 144 | Dysostosis multiplex (HP:0000943) | 1.82296144 |
| 145 | Progressive muscle weakness (HP:0003323) | 1.81711594 |
| 146 | Microcytic anemia (HP:0001935) | 1.81292978 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.80888298 |
| 148 | Increased variability in muscle fiber diameter (HP:0003557) | 1.80318681 |
| 149 | Basal cell carcinoma (HP:0002671) | 1.79690677 |
| 150 | Amyloidosis (HP:0011034) | 1.79452023 |
| 151 | Metaphyseal cupping (HP:0003021) | 1.79202694 |
| 152 | Abnormal platelet volume (HP:0011876) | 1.78628776 |
| 153 | Abnormality of iron homeostasis (HP:0011031) | 1.78528424 |
| 154 | Interstitial pulmonary disease (HP:0006530) | 1.78351439 |
| 155 | Erythema (HP:0010783) | 1.77709721 |
| 156 | Type 2 muscle fiber atrophy (HP:0003554) | 1.76178240 |
| 157 | Easy fatigability (HP:0003388) | 1.76172856 |
| 158 | Myelodysplasia (HP:0002863) | 1.76153940 |
| 159 | Achilles tendon contracture (HP:0001771) | 1.75049383 |
| 160 | Emphysema (HP:0002097) | 1.74211519 |
| 161 | Malnutrition (HP:0004395) | 1.73263956 |
| 162 | Fatigue (HP:0012378) | 1.72543320 |
| 163 | Long palpebral fissure (HP:0000637) | 1.69558886 |
| 164 | Deep venous thrombosis (HP:0002625) | 1.69155603 |
| 165 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68783401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.21933353 |
| 2 | TXK | 3.88904144 |
| 3 | TRIB3 | 3.49125951 |
| 4 | PRPF4B | 3.40471803 |
| 5 | SMG1 | 3.32697964 |
| 6 | STK16 | 2.80037727 |
| 7 | TYK2 | 2.60981541 |
| 8 | IKBKE | 2.50962683 |
| 9 | KIT | 2.33331771 |
| 10 | ZAP70 | 2.22671262 |
| 11 | MAP3K11 | 2.15047422 |
| 12 | TESK1 | 2.11175619 |
| 13 | TEC | 2.07620393 |
| 14 | JAK3 | 1.97550131 |
| 15 | IRAK4 | 1.95439829 |
| 16 | BTK | 1.93988232 |
| 17 | SRPK1 | 1.93293909 |
| 18 | BCKDK | 1.90972274 |
| 19 | FGFR4 | 1.88921158 |
| 20 | FLT3 | 1.86702821 |
| 21 | TAOK1 | 1.86328941 |
| 22 | MAP3K12 | 1.85435585 |
| 23 | TAOK2 | 1.83519689 |
| 24 | SIK1 | 1.80383869 |
| 25 | ICK | 1.80289080 |
| 26 | ADRBK2 | 1.76566594 |
| 27 | RIPK1 | 1.72244850 |
| 28 | BUB1 | 1.71169801 |
| 29 | KDR | 1.69589772 |
| 30 | TBK1 | 1.66209297 |
| 31 | CDK12 | 1.60082639 |
| 32 | MAP3K3 | 1.55936124 |
| 33 | PASK | 1.53029880 |
| 34 | ITK | 1.52886393 |
| 35 | EPHB1 | 1.51010433 |
| 36 | SYK | 1.49721027 |
| 37 | SIK3 | 1.49104512 |
| 38 | GRK6 | 1.45389404 |
| 39 | VRK1 | 1.45027338 |
| 40 | MAPK15 | 1.44218186 |
| 41 | BRSK2 | 1.42549813 |
| 42 | FES | 1.41852248 |
| 43 | TGFBR2 | 1.40100340 |
| 44 | MAP3K14 | 1.38314658 |
| 45 | WEE1 | 1.37595622 |
| 46 | NLK | 1.33448736 |
| 47 | CDK19 | 1.32875776 |
| 48 | TNK2 | 1.31911386 |
| 49 | MAPKAPK3 | 1.30678906 |
| 50 | EIF2AK1 | 1.28842518 |
| 51 | CSF1R | 1.25064612 |
| 52 | ACVR1B | 1.24073180 |
| 53 | IKBKB | 1.24041845 |
| 54 | ARAF | 1.20639508 |
| 55 | ERN1 | 1.20630341 |
| 56 | JAK1 | 1.20141985 |
| 57 | MAP3K1 | 1.19383486 |
| 58 | TSSK6 | 1.19356656 |
| 59 | KSR2 | 1.18001079 |
| 60 | IRAK3 | 1.17034832 |
| 61 | LCK | 1.15938675 |
| 62 | VRK2 | 1.15295962 |
| 63 | MAP3K10 | 1.14787926 |
| 64 | DAPK1 | 1.07986843 |
| 65 | PTK6 | 1.07795658 |
| 66 | CCNB1 | 1.07546350 |
| 67 | LRRK2 | 1.06982234 |
| 68 | PDPK1 | 1.04907977 |
| 69 | MST4 | 1.02546192 |
| 70 | LYN | 0.97484688 |
| 71 | MAP2K6 | 0.96570994 |
| 72 | MAPK11 | 0.92055972 |
| 73 | PRKD2 | 0.90461385 |
| 74 | FGFR3 | 0.90325258 |
| 75 | MAP3K13 | 0.86416370 |
| 76 | PRKD3 | 0.85824221 |
| 77 | RPS6KB2 | 0.85784333 |
| 78 | BMX | 0.85299304 |
| 79 | BLK | 0.84906420 |
| 80 | MARK2 | 0.84592612 |
| 81 | STK10 | 0.84465612 |
| 82 | EIF2AK3 | 0.84070222 |
| 83 | TTN | 0.83707510 |
| 84 | EEF2K | 0.82933506 |
| 85 | SIK2 | 0.81664302 |
| 86 | DYRK3 | 0.81545901 |
| 87 | TESK2 | 0.80189059 |
| 88 | BRSK1 | 0.80130321 |
| 89 | PIM1 | 0.79114353 |
| 90 | YES1 | 0.78820421 |
| 91 | TLK1 | 0.77555693 |
| 92 | PAK4 | 0.76668515 |
| 93 | HIPK2 | 0.76548560 |
| 94 | PDK1 | 0.74261605 |
| 95 | PINK1 | 0.73437916 |
| 96 | MAP3K8 | 0.72955345 |
| 97 | TIE1 | 0.72421055 |
| 98 | MYLK | 0.71061495 |
| 99 | CDC42BPA | 0.70533757 |
| 100 | CSK | 0.70526901 |
| 101 | CDK4 | 0.68122606 |
| 102 | INSRR | 0.67826567 |
| 103 | IRAK2 | 0.67393346 |
| 104 | MAPK7 | 0.67193172 |
| 105 | CHUK | 0.66680947 |
| 106 | PLK4 | 0.64647545 |
| 107 | PKN2 | 0.64496689 |
| 108 | MARK3 | 0.64298286 |
| 109 | FGR | 0.63079943 |
| 110 | TGFBR1 | 0.62835753 |
| 111 | AKT3 | 0.61854984 |
| 112 | SCYL2 | 0.59451235 |
| 113 | MAP2K2 | 0.58899504 |
| 114 | GRK1 | 0.57942576 |
| 115 | CDK8 | 0.56475105 |
| 116 | STK24 | 0.55974803 |
| 117 | PRKG2 | 0.55359859 |
| 118 | ATR | 0.54990762 |
| 119 | EPHA2 | 0.54336094 |
| 120 | HCK | 0.54112436 |
| 121 | BRD4 | 0.53727953 |
| 122 | STK38 | 0.50623003 |
| 123 | NEK2 | 0.50141744 |
| 124 | CLK1 | 0.47638150 |
| 125 | MAPK12 | 0.46133310 |
| 126 | EIF2AK2 | 0.46030270 |
| 127 | BRAF | 0.45194203 |
| 128 | MAPKAPK2 | 0.44365870 |
| 129 | JAK2 | 0.43750285 |
| 130 | MAP2K3 | 0.43260786 |
| 131 | MUSK | 0.42829896 |
| 132 | PDK2 | 0.42697271 |
| 133 | RIPK4 | 0.42204529 |
| 134 | RPS6KA2 | 0.42060101 |
| 135 | RPS6KA4 | 0.41930915 |
| 136 | FYN | 0.41777212 |
| 137 | RPS6KA6 | 0.41478806 |
| 138 | CDK6 | 0.40880218 |
| 139 | PIM2 | 0.40546252 |
| 140 | PAK1 | 0.39557007 |
| 141 | TAOK3 | 0.39417326 |
| 142 | CAMKK2 | 0.37563402 |
| 143 | ZAK | 0.37394526 |
| 144 | MTOR | 0.36663235 |
| 145 | CAMKK1 | 0.36626500 |
| 146 | DYRK1B | 0.36115294 |
| 147 | CDK7 | 0.35664827 |
| 148 | MATK | 0.35641967 |
| 149 | NME2 | 0.35556268 |
| 150 | BMPR2 | 0.34501121 |
| 151 | DAPK3 | 0.34469155 |
| 152 | ALK | 0.33907620 |
| 153 | PRKCD | 0.33001495 |
| 154 | RPS6KC1 | 0.32667115 |
| 155 | RPS6KL1 | 0.32667115 |
| 156 | LIMK1 | 0.31972035 |
| 157 | MAP3K5 | 0.31197709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.77211701 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.81883890 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.72955598 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.51964463 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.49416440 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.47547144 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.43924919 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37524229 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25743398 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.23581384 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.18222157 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.18211101 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.13302376 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.08583775 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90005612 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.89086162 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.85953241 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.77580054 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74302550 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74034929 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70249959 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66674623 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.66016949 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58168242 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51729261 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.51471964 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51238540 |
| 28 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.50988781 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48622274 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46874460 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45450814 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44248909 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.42542821 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.41722218 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.38830476 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37572023 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35476312 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.35443228 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30560116 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27449983 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26227442 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.24347577 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23907857 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23825537 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22753613 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21943818 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21338700 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.19224460 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.18028488 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.17419928 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17052354 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 1.16340334 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13177701 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12049598 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.10796205 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10776841 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.10363223 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10025681 |
| 59 | Malaria_Homo sapiens_hsa05144 | 1.08809839 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 1.08514209 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04612640 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 1.04597480 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04015209 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02831029 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02653939 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02437768 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01031091 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99398463 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97925735 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.94466498 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93508947 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.92335916 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91955710 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87736162 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87705472 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85244965 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83093485 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82788565 |
| 79 | RNA transport_Homo sapiens_hsa03013 | 0.82646653 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82026533 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82011124 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81647985 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81605766 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81402140 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81365303 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.81153396 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81087498 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.80889038 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79264083 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78407067 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78291918 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77961385 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77929183 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.76837540 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74854102 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.73542920 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73293025 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72154647 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.71790018 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71225961 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70102756 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67505197 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67432550 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67430132 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65352013 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.63858793 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63743304 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63102359 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.62466049 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61962071 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61549007 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60874253 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.60401523 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60224946 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.57709894 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56764838 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56383415 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56223451 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56014704 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55380476 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55266913 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54649684 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50957441 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50758978 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50709554 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.50568301 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50055122 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49389670 |
| 129 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48592083 |
| 130 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48222712 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.47574315 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.46721563 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46146708 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45966767 |
| 135 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45032500 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43992780 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43606676 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42436764 |
| 139 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40798213 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39694269 |
| 141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39444048 |
| 142 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38942854 |
| 143 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38861574 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36928340 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36034434 |
| 146 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35264389 |
| 147 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34666375 |
| 148 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33620739 |
| 149 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33568940 |
| 150 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33147530 |
| 151 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33041576 |
| 152 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31821918 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31164929 |
| 154 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29883118 |
| 155 | Apoptosis_Homo sapiens_hsa04210 | 0.29774296 |
| 156 | Shigellosis_Homo sapiens_hsa05131 | 0.29212167 |

